The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Thyroid Hormone Diseases and Osteoporosis
Open accessAbstract
Thyroid hormones are essential for normal skeletal development and normal bone metabolism in adults but can have detrimental effects on bone structures in states of thyroid dysfunction. Untreated severe hyperthyroidism influences the degree of bone mass and increases the probability of high bone turnover osteoporosis. Subclinical hyperthyroidism, defined as low thyrotropin (TSH) and free hormones within the reference range, is a subtler disease, often asymptomatic, and the diagnosis is incidentally made during screening exams. However, more recent data suggest that this clinical condition may affect bone metabolism resulting in decreased bone mineral density (BMD) and increased risk of fracture, particularly in postmenopausal women. The main causes of exogenous subclinical hyperthyroidism are inappropriate replacement dose of thyroxin and TSH suppressive L-thyroxine doses in the therapy of benign thyroid nodules and thyroid carcinoma. Available data similarly suggest that a long-term TSH suppressive dose of thyroxin may decrease BMD and may induce an increased risk of fracture. These effects are particularly observed in postmenopausal women but are less evident in premenopausal women. Overt hypothyroidism is known to lower bone turnover by reducing both osteoclastic bone resorption and osteoblastic activity. These changes in bone metabolism would result in an increase in bone mineralization. At the moment, there are no clear data that demonstrate any relationship between BMD in adults and hypothyroidism. Despite these clinical evidences, the cellular and molecular actions of thyroid hormones on bone structures are not complete clear.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“These findings are consistent with some studies [38, 45], suggesting that the duration of intervention may influence BMD.”
From Effects of levothyroxine therapy on bone and mineral metabolism in hypothyroidism: a systematic review and meta-analysis (2025) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013
Lim, H., Devesa, S. S., Sosa, J. A., Check, D., & Kitahara, C. M. (2017) · JAMA · doi:10.1001/jama.2017.2719 · Cited by 2,159
Molecular Aspects of Thyroid Hormone Actions
Cheng, S.-Y., Leonard, J. L., & Davis, P. J. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0007 · Cited by 1,384
Li, J., Sarosi, I., Yan, X.-Q., Morony, S., Capparelli, C., Tan, H.-L., McCabe, S., Elliott, R., Scully, S., Van, G., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1566 · Cited by 1,119
Bianco, P., & Robey, P. G. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10413 · Cited by 908
Arai, F., Miyamoto, T., Ohneda, O., Inada, T., Sudo, T., Brasel, K., Miyata, T., Anderson, D. M., & Suda, T. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.12.1741 · Cited by 693
TSH Is a Negative Regulator of Skeletal Remodeling
Abe, E., Marians, R. C., Yu, W., Wu, X.-B., Ando, T., Li, Y., Iqbal, J., Eldeiry, L., Rajendren, G., Blair, H. C., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00771-2 · Cited by 691
Subclinical Hypothyroidism: A Review
Biondi, B., Cappola, A. R., & Cooper, D. S. (2019) · JAMA · doi:10.1001/jama.2019.9052 · Cited by 604
Relative Contributions of Aging and Estrogen Deficiency to Postmenopausal Bone Loss
Richelson, L. S., Wahner, H. W., Melton, L. J., & Riggs, B. L. (1984) · New England Journal of Medicine · doi:10.1056/nejm198411153112002 · Cited by 539
Risk for fracture in women with low serum levels of thyroid-stimulating hormone
Bauer, D. C., Ettinger, B., Nevitt, M. C., Stone, K. L., & for the Study of Osteoporotic Fractures Research Group (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-7-200104030-00009 · Cited by 467
Direct stimulation of bone resorption by thyroid hormones.
Mundy, G. R., Shapiro, J. L., Bandelin, J. G., CANALIS, E. M., & Raisz, L. G. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108497 · Cited by 379
Faber, J., & Galløe, A. M. (1994) · European Journal of Endocrinology · doi:10.1530/eje.0.1300350 · Cited by 377
Thyrotropin-Releasing Hormone and the Thyroid Hormone Feedback Mechanism
Chiamolera, M. I., & Wondisford, F. E. (2009) · Endocrinology · doi:10.1210/en.2008-1795 · Cited by 356
Subclinical Thyroid Dysfunction and Fracture Risk: A Meta-analysis
Blum, M. R., Bauer, D. C., Collet, T.-H., Fink, H. A., Cappola, A. R., da Costa, B. R., Wirth, C. D., Peeters, R. P., Åsvold, B. O., den Elzen, W. P. J., et al. (2015) · JAMA · doi:10.1001/jama.2015.5161 · Cited by 343
Recker, R. R., Lappe, J. M., Davies, K. M., & Heaney, R. P. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040710 · Cited by 342
Hyperthyroidism, Bone Mineral, and Fracture Risk—A Meta-Analysis
Vestergaard, P., & Mosekilde, L. (2003) · Thyroid · doi:10.1089/105072503322238854 · Cited by 306
Structural and cellular changes during bone growth in healthy children
PARFITT, A. M., Travers, R., Rauch, F., & Glorieux, F. H. (2000) · Bone · doi:10.1016/s8756-3282(00)00353-7 · Cited by 286
Biondi, B., & Cooper, D. S. (2010) · Thyroid · doi:10.1089/thy.2009.0311 · Cited by 286
The Effect of Thyroid Hormone on Skeletal Integrity
Greenspan, S. L., & Greenspan, F. S. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-9-199905040-00016 · Cited by 249
Diamond, T. H., Nery, L., & Hales, I. B. (1991) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem-72-6-1184 · Cited by 225
Accelerated Bone Loss in Hypothyroid Patients Overtreated with L-Thyroxine
Stall, G. M., Harris, S., Sokoll, L. J., & Dawson-Hughes, B. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-4-265 · Cited by 203
Földes, J., Tarján, G., Szathmari, M., Varga, F., Krasznai, I., & Horvath, C. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb02403.x · Cited by 170
Subclinical hypothyroidism, lipid metabolism and cardiovascular disease
Delitala, A., Fanciulli, G., Maioli, M., & Delitala, G. (2016) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2016.12.015 · Cited by 168
Self-citationThe expression of thyroid hormone receptors in human bone.
Abu, E. O., Bord, S., Horner, A., Chatterjee, V., & Compston, J. (1996) · Bone · doi:10.1016/s8756-3282(97)00097-5 · Cited by 159
Faber, Jensen, Petersen, Nygaard, Hegedüs, & Siersbæk‐Nielsen (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00427.x · Cited by 156
Kumar, S., Nadeem, S., Stan, M. N., Coenen, M., & Bahn, R. S. (2011) · Journal of Molecular Endocrinology · doi:10.1530/jme-11-0006 · Cited by 150
Krølner, B. K., Jørgensen, J., & Nielsen, S. P. (1983) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1983.tb02873.x · Cited by 145
The skeletal consequences of thyrotoxicosis
Nicholls, J. J., Brassill, M. J., Williams, G. R., & Bassett, J. H. D. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0059 · Cited by 138
Nuclear thyroid hormone receptors in cultured bone cells
Rizzoli, R., Poser, J. W., & Bürgi, U. (1986) · Metabolism · doi:10.1016/0026-0495(86)90098-3 · Cited by 137
Molecular Mechanisms of Thyroid Hormone Effects on Bone Growth and Function
Harvey, C. B., O'Shea, P. J., Scott, A. J., Robson, H., Siebler, T., Shalet, S. M., Samarut, J., Chassande, O., & Williams, G. R. (2002) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2001.3268 · Cited by 133
Morris, M. S. (2007) · Bone · doi:10.1016/j.bone.2006.12.001 · Cited by 129
TNFα mediates the skeletal effects of thyroid-stimulating hormone
Hase, H., Ando, T., Eldeiry, L. S., Brebene, A., Peng, Y., Liu, L., Amano, H., Davies, T. F., Sun, L., Zaidi, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600427103 · Cited by 127
Persistent Increase in Bone Turnover in Graves’ Patients with Subclinical Hyperthyroidism
Kumeda, Y., Inaba, M., Tahara, H., Kurioka, Y., Ishikawa, T., Morii, H., & Nishizawa, Y. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.11.6979 · Cited by 123
Bassett, J. H. D., Williams, A. J., Murphy, E., Boyde, A., Howell, P. G., Swinhoe, R., Archanco, M., Flamant, F., Samarut, J., Costagliola, S., et al. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0221 · Cited by 110
Thyroid hormone metabolism in skeletal development and adult bone maintenance
Waung, J. A., Bassett, J. H. D., & Williams, G. R. (2011) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2011.11.002 · Cited by 103
Taelman, P., Kaufman, J.-M., Janssens, X., Vandecauter, H., & Vermeulen, A. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb00471.x · Cited by 100
Hutchings, G., Moncrieff, L., Dompé, C., Janowicz, K., Sibiak, R., Bryja, A., Jankowski, M., Mozdziak, P. E., Bukowska, D., Antosik, P., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010139 · Cited by 93
The Effects of Recombinant TSH on Bone Turnover Markers and Serum Osteoprotegerin and RANKL Levels
Martini, G., Gennari, L., Paola, V. D., Pilli, T., Salvadori, S., Merlotti, D., Valleggi, F., Campagna, S., Franci, B., Avanzati, A., et al. (2008) · Thyroid · doi:10.1089/thy.2007.0166 · Cited by 91
Segna, D., Bauer, D. C., Feller, M., Schneider, C., Fink, H. A., Aubert, C. E., Collet, T. ‐., da Costa, B. R., Fischer, K., Peeters, R. P., et al. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12688 · Cited by 87
Sornay‐Rendu, E., Munoz, F., Duboeuf, F., & Delmas, P. D. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050704 · Cited by 86
Subclinical Thyroid Dysfunction and the Risk for Fractures: A Systematic Review and Meta-analysis
Wirth, C. D., Blum, M. R., da Costa, B. R., Baumgartner, C., Collet, T.-H., Medici, M., Peeters, R. P., Aujesky, D., Bauer, D. C., & Rodondi, N. (2014) · Annals of Internal Medicine · doi:10.7326/m14-0125 · Cited by 85
Reverter, J. L., Holgado, S., Alonso, N., Salinas, I., Granada, M. L., & Sanmartı́, A. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.01072 · Cited by 82
Relationship between Subclinical Thyroid Dysfunction and Femoral Neck Bone Mineral Density in Women
Lee, W., Oh, K. W., Rhee, E., Jung, C., Kim, S. W., Yun, E. J., Tae, H. J., Baek, K. H., Kang, M. I., Choi, M. G., et al. (2006) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.09.009 · Cited by 78
Jódar, E., Muñoz‐Torres, M., Escobar‐Jiménez, F., Quesada‐Charneco, M., & del Castillo, J. D. L. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.2261041.x · Cited by 73
GÜRLEK, A., & GEDIK, O. (1999) · Thyroid · doi:10.1089/thy.1999.9.539 · Cited by 72
DIAGNOSIS OF ENDOCRINE DISEASE: Evaluation of bone fragility in endocrine disorders
Eller-Vainicher, C., Falchetti, A., Gennari, L., Cairoli, E., Bertoldo, F., Vescini, F., Scillitani, A., & Chiodini, I. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-0991 · Cited by 66
Tauchmanovà, L., Nuzzo, V., Del Puente, A., Fonderico, F., Esposito-Del Puente, A., Padulla, S., Rossi, A., Bifulco, G., Lupoli, G., & Lombardi, G. (2004) · Maturitas · doi:10.1016/j.maturitas.2004.02.017 · Cited by 66
Garin, M. C., Arnold, A. M., Lee, J. S., Robbins, J., & Cappola, A. R. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1051 · Cited by 65
Subclinical hypothyroidism and cardiovascular risk factors
Delitala, A., Scuteri, A., Maioli, M., Mangatia, P., Vilardi, L., & Erre, G. L. (2020) · Minerva Medica · doi:10.23736/s0026-4806.19.06292-x · Cited by 64
Self-citationHigh serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment
Amato, G., Mazziotti, G., Sorvillo, F., Piscopo, M., Lalli, E., Biondi, B., Iorio, S., Molinari, A. M., Giustina, A., & Carella, C. (2004) · Bone · doi:10.1016/j.bone.2004.04.021 · Cited by 53
Delitala, A., Filigheddu, F., Orrù, M., AlGhatrif, M., Steri, M., Pilia, M. G., Scuteri, A., Lobina, M., Piras, M. G., Delitala, G., et al. (2015) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2015.09.001 · Cited by 52
Self-citationDepressive symptoms, thyroid hormone and autoimmunity in a population-based cohort from Sardinia
Delitala, A., Terracciano, A., Fiorillo, E., Orrù, V., Schlessinger, D., & Cucca, F. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.11.019 · Cited by 51
Self-citationSubclinical Hyperthyroidism and the Cardiovascular Disease
Delitala, A. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-117893 · Cited by 51
Self-citationvan Rijn, L. E., Pop, V. J., & Williams, G. R. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-0769 · Cited by 50
Thyroid Hormones, Metabolic Syndrome and Its Components
Delitala, A., Fanciulli, G., Pes, G. M., Maioli, M., & Delitala, G. (2017) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530317666170320105221 · Cited by 47
Self-citationYoon, B.-H., Lee, Y., Oh, H. J., Kim, S. H., & Lee, Y.-K. (2019) · Journal of Bone Metabolism · doi:10.11005/jbm.2019.26.1.51 · Cited by 46
Bone mineral density in premenopausal women receiving levothyroxine suppressive therapy
Nuzzo, V., Lupoli, G., Puente, A. D., Rampone, E., Carpinelli, A., Puente, A. E. D., & Oriente, P. (1998) · Gynecological Endocrinology · doi:10.3109/09513599809012835 · Cited by 45
Prevalence of unknown thyroid disorders in a Sardinian cohort
Delitala, A., Pilia, M. G., Ferreli, L., Loi, F., Curreli, N., Balaci, L., Schlessinger, D., & Cucca, F. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0182 · Cited by 43
Self-citationSiru, R., Alfonso, H. S., Chubb, S. A. P., Golledge, J., Flicker, L. A., & Yeap, B. B. (2018) · Clinical Endocrinology · doi:10.1111/cen.13615 · Cited by 40
Serum free thyroxine levels are positively associated with arterial stiffness in the Sardi NIA study
Delitala, A., Orrù, M., Filigheddu, F., Pilia, M. G., Delitala, G., Ganau, A., Saba, P. S., Decandia, F., Scuteri, A., Marongiu, M., et al. (2014) · Clinical Endocrinology · doi:10.1111/cen.12532 · Cited by 39
Self-citation(2007) · PubMed · Cited by 39
Self-reported diseases and the risk of non-vertebral fractures: the Tromsø study
Ahmed, L. A., Schirmer, H., Berntsen, G., Fønnebø, V. M., & Joakimsen, R. M. (2005) · Osteoporosis International · doi:10.1007/s00198-005-1892-6 · Cited by 38
Langdahl, B. L., Loft, A. G., Eriksen, E. F., Mosekilde, L., & Charles, P. (1996) · PubMed · doi:10.1089/thy.1996.6.169 · Cited by 37
Rosário, P. W., Carvalho, M. U. W. B. D., Mourão, G. F., & Calsolari, M. R. (2016) · Thyroid · doi:10.1089/thy.2015.0445 · Cited by 37
Gam, A. N., JENSEN, G. F., Hasselström, K., Olsen, M., & Nielsen, K. (1991) · Journal of Endocrinological Investigation · doi:10.1007/bf03346838 · Cited by 36
Rinaldi, S., Maioli, M., Santaniello, Pigliaru, Ventura, Montela, Sanna, R., Bandiera, P., Bagella, L., Delitala, A., et al. (2013) · Drug Design Development and Therapy · doi:10.2147/dddt.s44706 · Cited by 36
Self-citationDelitala, A., Scuteri, A., Fiorillo, E., Lakatta, E. G., Schlessinger, D., & Cucca, F. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8060764 · Cited by 35
Self-citationBuscemi, S., Verga, S., Cottone, S., Andronico, G., D’Orio, L., Mannino, V., Panzavecchia, D., Vitale, F., & Cerasola, G. (2007) · Journal of Endocrinological Investigation · doi:10.1007/bf03347430 · Cited by 35
Mendonça Monteiro de Barros, G., Madeira, M., Vieira Neto, L., de Paula Paranhos Neto, F., Carvalho Mendonça, L. M., Corrêa Barbosa Lima, I., Corbo, R., & Fleiuss Farias, M. L. (2016) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-015-0680-4 · Cited by 34
Moon, J. H., Jung, K. Y., Kim, K. M., Choi, S. H., Lim, S. K., Park, Y. J., Park, D. J., & Jang, H. C. (2015) · Bone · doi:10.1016/j.bone.2015.10.015 · Cited by 33
Ding, B., Zhang, Y., Li, Q., Hu, Y., Tao, X.-J., Liu, B.-L., Ma, J., & Li, D. M. (2016) · Archives of Medical Research · doi:10.1016/j.arcmed.2016.07.009 · Cited by 32
Giusti, M., Cecoli, F., Ghiara, C., Rubinacci, A., Villa, I., Cavallero, D., Mazzuoli, L., Mussap, M., Lanzi, R., & Minuto, F. M. (2007) · HORMONES · doi:10.14310/horm.2002.1111026 · Cited by 31
Appetecchia, M. (2005) · Hormone Research in Paediatrics · doi:10.1159/000089489 · Cited by 30
The Role of T Lymphocytes in Autoimmune Thyroid Disease
Ahmann, A., & Burman, K. D. (1987) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30481-x · Cited by 30
Leali, P. T. (2016) · Clinical cases in mineral and bone metabolism · doi:10.11138/ccmbm/2016.13.3.234 · Cited by 29
Thyroid hormone analogs for the treatment of dyslipidemia: past, present, and future
Delitala, A. P., Delitala, G., Sioni, P., & Fanciulli, G. (2017) · Current Medical Research and Opinion · doi:10.1080/03007995.2017.1330259 · Cited by 29
Self-citationIs Antithyroid Treatment Really Relevant for Young Patients with Subclinical Hyperthyroidism?
Yönem, Ö., Dökmetaş, H. S., Aslan, S. M., & Erselcan, T. (2002) · Endocrine Journal · doi:10.1507/endocrj.49.307 · Cited by 27
Lee, K., Lim, S., Park, H. H., Woo, H., Chang, Y., Sung, E., Jung, H. S., Yun, K. E., Kim, C., Ryu, S., et al. (2019) · Osteoporosis International · doi:10.1007/s00198-019-05205-1 · Cited by 27
Effects of Thyrotropin Suppression on Bone Health in Menopausal Women with Total Thyroidectomy
Kim, E. H., Jeon, Y. K., Pak, K., Kim, I.-J., Kim, S.-J., Shin, S., Kim, B. H., Kim, S. S., Lee, B.-J., Lee, J.-G., et al. (2019) · Journal of Bone Metabolism · doi:10.11005/jbm.2019.26.1.31 · Cited by 26
Bone and heart abnormalities of subclinical hyperthyroidism in women below the age of 65 years
Rosário, P. W. (2008) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302008000900007 · Cited by 25
The impact of thyroid autoimmunity (TPOAb) on bone density and fracture risk in postmenopausal women
Polovina, S. P., Miljić, D., Zivojinović, S., Milic, N. M., Micić, D., & Popović-Brkić, V. (2017) · HORMONES · doi:10.14310/horm.2002.1719 · Cited by 25
Treatment of Osteoporosis: Unmet Needs and Emerging Solutions
Langdahl, B. L., & Andersen, J. D. (2018) · Journal of Bone Metabolism · doi:10.11005/jbm.2018.25.3.133 · Cited by 25
Bone Mineral Density After Surgical Treatment for Graves' Disease
Arata, N., Momotani, N., Maruyama, H., Saruta, T., TSUKATANI, K., Kubo, A., IKEMOTO, K., & Ito, K. (1997) · Thyroid · doi:10.1089/thy.1997.7.547 · Cited by 23
Wu, Q. F., Xiao, X., & Xu, Y. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020499 · Cited by 22
Ugur‐Altun, B., Altun, A., Arikan, E., Guldiken, S., & Tugrul, A. (2003) · Endocrine Research · doi:10.1081/erc-120026945 · Cited by 22
Rosario, P. W. (2013) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302013000200008 · Cited by 19
Rosário, P. W., Carvalho, M. U. W. B. D., & Calsolari, M. R. (2015) · Clinical Endocrinology · doi:10.1111/cen.12979 · Cited by 18
Adipocytokine correlations with thyroid function and autoimmunity in euthyroid sardinians
Delitala, A., Steri, M., Fiorillo, E., Marongiu, M., Lakatta, E. G., Schlessinger, D., & Cucca, F. (2018) · Cytokine · doi:10.1016/j.cyto.2018.08.027 · Cited by 17
Self-citationUse of teriparatide off-label: our experience and review of literature
Ciurlia, E. (2017) · Clinical cases in mineral and bone metabolism · doi:10.11138/ccmbm/2017.14.1.028 · Cited by 17
Caggiari, G. (2016) · Clinical cases in mineral and bone metabolism · doi:10.11138/ccmbm/2016.13.3.200 · Cited by 13
Bone mineral density trends in Indian patients with hyperthyroidism--effect of antithyroid therapy.
Dhanwal, D. K., & Gupta, N. (2011) · PubMed · Cited by 12
Trends and Disparities in Self-Reported and Measured Osteoporosis among US Adults, 2007–2014
Wu, Q. F., Xu, Y., & Lin, G. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122052 · Cited by 12
LECOMTE, P., Lécureuil, N., OSORIO-SALAZAR, C., Lécureuil, M., & Valat, C. (1995) · Thyroid · doi:10.1089/thy.1995.5.19 · Cited by 12
Endogenous subclinical hyperthyroidism may not lead to bone loss in premenopausal women.
Saler, T., Ahbab, S., Sağlam, Z. A., Keşkek, Ş. Ö., & Kurnaz, S. (2014) · PubMed Central · Cited by 11
Subclinical Hyperthyroidism in Patients with Nodular Goiter Represents a Hypermetabolic State
Kvetny, J. (2005) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2004-830541 · Cited by 8 · cited 1×
“Decreased BMD was observed in a small group of patients with subclinical hyperthyroidism with nodular goiter [50].”
BackgroundAhn, K. H., Lee, S. H., Park, H. T., Kim, T., Hur, J. Y., Kim, Y. T., & Kim, S. H. (2010) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2009.01132.x · Cited by 7
Doria, C., Mosele, G. R., Solla, F., Maestretti, G. I., Balsano, M., & Scarpa, R. M. (2017) · Minerva Urology and Nephrology · doi:10.23736/s0393-2249.16.02808-3 · Cited by 7
Self-citationBone mineral density in geriatric patients with toxic nodular goiter
Şahin, S. B., Ayaz, T., Sümer, F., İlkkılıç, K., & Algün, E. (2014) · Aging Clinical and Experimental Research · doi:10.1007/s40520-014-0269-0 · Cited by 6
Exogenous Subclinical Hyperthyroidism During Adolescence: Effect on Peak Bone Mass
Poomthavorn, P., Mahachoklertwattana, P., Ongphiphadhanakul, B., PREEYASOMBAT, C., & Rajatanavin, R. (2005) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2005.18.5.463 · Cited by 6
Delitala, A., Manzocco, M., Sinibaldi, F. G., & Fanciulli, G. (2018) · International Journal of Clinical Practice · doi:10.1111/ijcp.13254 · Cited by 6
Self-citation
Research works printed but not linked: 1
- Maioli, 2013, Amniotic fluid stem cells morphinto a cardiovascular lineage: Analysis of a chemically induced cardiac andvascular commitment, Drug Des. Devel. Ther., 7, 1063
Cited by
Sorted by citations
Therapeutic Potential of Centella asiatica and Its Triterpenes: A Review
Sun, B., Wu, L., Wu, Y., Zhang, C., Qin, L., Hayashi, M., Kudo, M., Gao, M., & Liu, T. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.568032 · Cited by 353
Pathophysiology and treatment of osteoporosis: Challenges for clinical practice in older people
Barnsley, J., Buckland, G., Chan, P. E., Ong, A., Ramos, A. S., Baxter, M., Laskou, F., Dennison, E. M., Cooper, C., & Patel, H. P. (2021) · Aging Clinical and Experimental Research · doi:10.1007/s40520-021-01817-y · Cited by 199
The Role of Osteoclast Energy Metabolism in the Occurrence and Development of Osteoporosis
Da, W., Tao, L., & Zhu, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.675385 · Cited by 185
Secondary Osteoporosis and Metabolic Bone Diseases
Sobh, M., Abdalbary, M., Elnagar, S., Nagy, E., Elshabrawy, N. A., Abdelsalam, M., Asadipooya, K., & El-Husseini, A. A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11092382 · Cited by 165
Hutchings, G., Moncrieff, L., Dompé, C., Janowicz, K., Sibiak, R., Bryja, A., Jankowski, M., Mozdziak, P. E., Bukowska, D., Antosik, P., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010139 · Cited by 93
Metadata
- Authors
- Delitala, A. P., Scuteri, A., & Doria, C.
- Affiliations
- University of Sassari (IT)
- Corresponding author
- Delitala, Alessandro P.
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2020-04-06
- Volume
- 9
- Issue
- 4
- Pages
- 1034
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC7230461
- OpenAlex
- W3015134906
- Cited by
- 220
- References
- 100
- Citations by year
- 2026: 27 · 2025: 40 · 2024: 51 · 2023: 36 · 2022: 33 · 2021: 27 · 2020: 5
- FWCI
- 3.87
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UnissResearch (Università degli Studi di Sassari) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Keywords
- thyroid hormones, osteoporosis, subclinical hyperthyroidism, hyperthyroidism, overt hypothyroidism, bone mineral density, bone turnover, fracture risk, postmenopausal women, TSH suppression therapy, levothyroxine, thyroid nodules, thyroid cancer, bone metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
